Autogenomics

The global carrier screening market is projected to grow at a strong CAGR of approximately 17% from 2022 to 2028. The increasing prevalence of genetic disorders, such as cystic fibrosis, sickle cell anemia, and Marfan syndrome, is a key driver of market growth. According to the Cystic Fibrosis Foundation, it is estimated that over 30,000 children and adults in the United States have cystic fibrosis. Additionally, growing awareness of the importance of early detection and prevention of genetic diseases, the rising trend towards personalized medicine, and increasing adoption of screening tests for genetic disorders are expected to further fuel market growth during the forecast period.
To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=147814
Market Trends:
· Increasing Prevalence of Genetic Disorders: The rising incidence of genetic disorders such as cystic fibrosis, sickle cell anemia, and Marfan syndrome is driving the demand for carrier screening tests to identify carriers of these genetic mutations and enable informed reproductive decisions.
· Growing Awareness and Adoption of Genetic Testing: Increasing awareness of the importance of early detection and prevention of genetic diseases is encouraging more individuals to undergo carrier screening tests, thereby boosting market growth.
· Advancements in Genetic Testing Technologies: Continuous advancements in genetic testing technologies, including next-generation sequencing (NGS) and multiplex PCR, are enhancing the accuracy, reliability, and efficiency of carrier screening tests, making them more accessible and affordable.
· Rising Trend towards Personalized Medicine: The growing trend towards personalized medicine is increasing the demand for carrier screening tests to tailor medical interventions and treatments based on an individual's genetic profile, thereby driving market growth.
· Expansion of Screening Programs and Policies: The implementation of carrier screening programs and policies by healthcare organizations and governments to reduce the burden of genetic diseases and improve public health is contributing to the growth of the carrier screening market.
Market Opportunities:
The global carrier screening market presents several promising opportunities driven by the increasing prevalence of genetic disorders, growing awareness and adoption of genetic testing, and advancements in genetic testing technologies. With the rising demand for early detection and prevention of genetic diseases, carrier screening tests are well-positioned to capitalize on the expanding market for personalized medicine and the integration of carrier screening into routine healthcare practices. Additionally, the implementation of carrier screening programs and policies by healthcare organizations and governments, coupled with the increasing focus on preconception and prenatal screening, offers opportunities to expand the market reach and accessibility of carrier screening tests. The growing demand for direct-to-consumer genetic testing services and the potential for strategic collaborations and partnerships with healthcare organizations and research institutions also provide avenues for market growth and expansion.
According to the recent report published by RC Market Analytics, the Global Carrier Screening Market is expected to provide sustainable growth opportunities during the forecast period from 2023 to 2030. This latest industry research study analyzes the carrier screening market by various product segments, applications, regions and countries while assessing regional performances of numerous leading market participants. The report offers a holistic view of the carrier screening industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others. Furthermore, the report includes detailed quantitative and qualitative analysis of the global market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.
Browse the Full Report Discretion @ https://www.researchcorridor.com/carrier-screening-market/
Geographically, the carrier screening market report comprises dedicated sections centering on the regional market revenue and trends. The carrier screening market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Carrier screening market estimates have also been provided for the historical years 2020 & 2021 along with forecast for the period from 2023 - 2030.The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, Italy, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others. Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.
The Carrier Screening Market Segmentation:

By Type:

• Expanded
  • Customized Panel Testing
  • Predesigned Panel Testing
• Targeted Disease

By Technology:

• DNA Sequencing
• Polymerase Chain Reaction (PCR)
• Microarrays
• Others

By Medical Condition:

• Pulmonary Conditions
• Hematological Conditions
• Neurological Conditions
• Others

By End-User:

• Hospitals
• Reference Laboratories
• Physician Offices & Clinics
• Other

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Major companies in the global carrier screening market include Eurofins Scientific, Opko Health, Invitae Corporation, Autogenomics Inc., and Fulgent Genetics. These companies are expanding their market presence through new investments, the introduction of innovative services, strategic collaborations, and acquisitions. For example, in July 2018, Myriad Genetics Inc. acquired Counsyl, Inc. to enhance its genetic testing portfolio in the market. Many players are also exploring new geographical markets through expansion and acquisition to gain a competitive edge and leverage combined strengths.
To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=147814
Key Questions Answered by Carrier Screening Market Report:

• Product popularity and adoption based on various country-level dynamics
• Regional presence and product development for leading market participants
• Market forecasts and trend analysis based on ongoing investments and economic growth in key countries
• Competitive landscape based on revenue, product offerings, years of presence, number of employees and market concentration, among others
• Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to Carrier Screening market
• Analysis of the key factors driving and restraining the growth of the global, regional and country-level markets from 2020-2027

About Us: RC Market Analytics is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities to optimize strategies. Our expert’s team of analysts’ provides enterprises with strategic insights. RC Market Analytics works to help enterprises grow through strategic insights and actionable solutions. Feel free to contact us for any report customization at sales@researchcorridor.com.
​
Media Contact:
Company Name: RC Market Analytics Pvt. Ltd. Contact Person: Vijendra Singh Email: sales@researchcorridor.com Visit us: https://www.researchcorridor.com/

Research Corridor The “Global Carrier Screening Market Size, Share, Trends, Industry Growth by Type (Expanded, Targeted Disease), by Technology (DNA Sequencing, PCR, Microarrays, Others), by Medical Condition, by End-User, by Region, and Forecast to 2028” Market research study gives a detailed view of current and future trends and opportunities analysis covers the industry share across different segments. The researcher provides an extensive analysis of the Carrier Screening Market size, share, trends, overall earnings, gross revenue, and profit margin to accurately draw a forecast and also provide expert insights to investors to keep them updated with the trends in the market.
The study conducts a SWOT analysis to evaluate the strengths and weaknesses of the key players in the market. Furthermore, the study gives a statistical representation of their progress during the course of the forecast period. It also highlights action plans and industry roadmaps for different value chain analyses.
Request Sample Report of Carrier Screening Market @ https://www.rcmarketanalytics.com/request-sample/?id=168
Top Market Players
​

• Eurofins Scientific
• Opko Health
• Invitae Corporation
• Autogenomics Inc.
• Fulgent Genetics
• Danaher Corporation
• Myriad Genetics
• Quest Diagnostics
• Thermo Fisher Scientific
• Illumina Inc.

Competitive Landscape
The competitive landscape is an important aspect that all key players should be aware of. This report throws light on the competitive scenario of the Carrier Screening market to know competition at the national and global levels. Market experts have also described all the major players in the Carrier Screening market, taking into account key aspects such as area of operation, production, and product portfolio. Additionally, the companies included in the report are studied based on key factors such as company size, market share, market growth, revenue, output, and profit.
Key questions answered in the report:
· What is the growth potential of the Carrier Screening market?
· Which regional market will emerge as a frontrunner in the coming years?
· What are the growth opportunities that may emerge in the Carrier Screening industry in the years to come?
· What are the key challenges that the global Carrier Screening market may face in the future?
· What will be the global market size over the coming future?
· What are the different effective business strategies followed by global companies?
Need More Information? Inquire more about this report before purchase @ https://www.rcmarketanalytics.com/inquiry/?id=168
Finally, the Carrier Screening Market report is a believable source for gaining Market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and Market development rate and figure, and so on. Carrier Screening industry report additionally Present a new task SWOT examination, speculation attainability investigation, and venture return investigation.
Market Segmentation
The segmentation chapter enables the reader to understand aspects of the Global Carrier Screening Market such as products / services, available technologies, and applications. This chapter is written to describe the years of development and the process that will unfold in the years to come. The research reports also provide insightful information on emerging trends that may define the progression of these segments over the next few years.
Browse detail report with in-depth TOC Here @ https://www.rcmarketanalytics.com/carrier-screening-market/
Overview of the Regional Outlook of this Market:
The Carrier Screening market report provides information about the market regions, which are themselves divided into sub-regions and countries. In addition to the market share of each country and sub-region, information on the lucrative opportunities is included in this chapter of the report. The share and market growth rates of each region, country and sub-region are mentioned in this chapter of the report during the estimated period.
· North America (USA, Canada)
· Europe (Germany, France, United Kingdom, Italy, Russia, Spain, Netherlands, Switzerland, Belgium)
· Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Vietnam)
· Middle East and Africa (Turkey, Saudi Arabia, United Arab Emirates, South Africa, Israel, Egypt, Nigeria)
· Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru).
About Us: Research Corridor is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 60,000+ market research reports with detailed & minute market research.
Media Contact:
Company Name: RC Market Research Contact Person: Mr. Vijendra Singh Email: [sales@rcmarketanalytics.com](mailto:sales@rcmarketanalytics.com)
Visit Us: https://www.rcmarketanalytics.com/

List of the Leading Companies Profiled in the Prenatal Genetic Testing Market are:
Bio-Rad Laboratories Inc., Agilent Technologies Inc., Illumina, Inc, Natera Inc., Abbott, Cepheid, ELITech Group, Autogenomics, Sequenom, GeneDx, 23andMe, Inc., Ambry Genetics, Invitae Corporation, Pathway Genomics, Progenity, Inc
Prenatal Genetic Testing Market: Segmentation
By Technology {Diagnostics Methods (PCR, Acgh, FISH), Screening Methods (Non-Invasive Prenatal Tests, Maternal Serum Screening)}
https://www.pharmiweb.com/press-release/2022-03-08/prenatal-genetic-testing-market-size-industry-growth-competitive-analysis-future-prospects-and-fo
This was also in the article 👇
The acquisition of small market applicants by leading players and high initial capital investments and strict government guidelines for prenatal genetic tests are to further extend profitable opportunities
Here is my view on it...Small market applicant, that's 🐸. Acquisition by leading players, 🤝 everyone has their own opinion as to who they might be. Leading players plan to extend profitable opportunities...this article is only talking about Non-Invasive Prenatal Tests but everyone here has heard of our patent line up. Prog has potential, that's all there is to it. 🚀🚀🚀🚀🚀🚀
Dont forget, we are awfully close...
Clinical Validation: PRO-104 Study
Achieved primary endpoint of validation study protocol
Demonstrated strong performance and a high NPV level in line with original target at high prevalence rate and in a broad use population
Received patent on methods for testing free and dissociated PlGF
Proceeding toward publication of results in peer-reviewed journal

This is the 5th article I've seen within the last 24 hours where Progenity has been mentioned, 3 of which were written by these guys.
Key Market Players mentioned in this report: Bio-Rad Laboratories Inc., Agilent Technologies Inc., Illumina, Inc, Natera Inc., Abbott, Cepheid, ELITech Group, Autogenomics, Sequenom, GeneDx, 23andMe, Inc., Ambry Genetics, Invitae Corporation, Pathway Genomics, Progenity
https://znewsafrica.com/news/191185/prenatal-genetic-testing-market-innovation-demand-growth-development-research-by-forecast-to-2028/

Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the patients.
Nucleic acid test, or nucleic acid amplification test (NAT/NAAT) is another molecular technology used in identification of a bacterium or virus. NAT comprises of all the tests and technologies used to identify genetic material of infecting virus or organism.
Get Free Sample Copy With Impact Analysis Of COVID-19 Of Market Report @ https://www.persistencemarketresearch.com/samples/5291
The market of molecular diagnostics is segmented on the basis of technology used in the diagnostic purposes, such as, amplification technologies, amplified gene detection technologies, DNA and oligonucleotide microarrays, and gene sequencing. Amplification technologies further segmented into multiple displacement amplification, ligase chain reaction, bio-barcode amplification assay, nucleic acid sequence based amplification, branched DNA and others. DNA microarrays are sub-segmented into array comparative genomic hybridization. Gene sequencing technique is divided into next generation sequencing and Sanger sequencing, whereas amplified gene detection technique is divided into microplate based flow cytometry and high resolution melting analysis. Further, the market is segmented on the basis of applications in the diagnosis of various diagnosis, such as, HIV diagnosis, influenza virus detection, hepatitis virus detection (hepatitis B and hepatitis C), STD testing, tuberculosis (Tb), Chlamydia testing, herpes simplex virus diagnosis, HPV, and many others. Moreover, molecular diagnostic tests are also applicable in the case of cancer, prenatal testing and disease risk management. The market for NAT is divided on the basis of various nucleic acid tests, such as, ligase chain reaction, reverse transcriptase PCR, quantiplex bDNA tests and others.
Moreover, the market is segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World (RoW). At present, the North American region is the most prominent market, owing to extensive diagnostic practices and R&D. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in research and diagnostic technologies.
The market is driven by various growth propellers, such as, increased prevalence of infectious diseases, extensive R&D in diagnostic and medical imaging field, development of advanced diagnosis equipment due to technological growth and increased demand for sophisticated diagnostic tests by patients and healthcare professionals. Increased prevalence of chronic infectious diseases is one of the most prominent drivers of the market growth. According to WHO, AIDS is the world’s first deadliest disease. As of 2012, around 35.5 million people of the world suffers from AIDS and in 2012, AIDS killed around 1.6 million people.
You Can Buy This PMR Healthcare Report From Here @ https://www.persistencemarketresearch.com/checkout/5291
Further, technological innovations are another market driver. Due to development of various technologically sound devices, the reliability of tests has been increased and it fuels the market growth. On the other hand, major growth hurdles include technological limitations and lack of awareness in certain region of the world and high costs associated with testing and equipment maintenance. Major opportunities include the development of cost-effective and hyper-accurate diagnostic tests and equipment, accomplished by awareness campaigns across the globe.
Major players operating in this market include Roche Diagnostics, Inc., Abbott Diagnostics Care, Becton, Dickinson and Company, GenMark Dx, Siemens Healthcare, AutoGenomics and others.

Molecular diagnostics market is growing at a significant rate due to increasing awareness for the same and rising investments in the field. Genetic testing refers to a process of analysis of human DNA in any of its form or related products such as RNA, chromosomes, DNA and others. Genetic testing is widely used for detection of diseases that are related to genotype, phenotype or mutation. Also, genetic testing is done to detect karyotype for clinical purposes. Popularity of genetic testing is increasing due to various advantages offered by this procedure such as detection of genetic abnormalities in early gestation period of about 8 to 10 weeks. In addition, it also helps to determine the sex the fetus. Genetic testing market is growing at a significant rate due to increasing awareness and discoveries in the field. Of all the tests performed for genetic testing, screening for genetic mutations with Cystic Fibrosis Trans-Membrane Conductance Regulator (CFTR) gene is most widely performed.
Get Free Sample Copy With Impact Analysis Of COVID-19 Of Market Report @ https://www.persistencemarketresearch.com/samples/3175
North America dominates the global market for genetic testing due to increasing prevalence of diseases by genetic disorders and high technological advancement in the region. Europe, followed by Asia, is expected to show high growth rate in the next few years in genetic testing market. China and India are expected to be the fastest growing genetic testing markets in Asian region. Some of the key driving forces for genetic testing market in emerging countries are increasing R&D investment, large pool of patients and rising government funding.
Various factors such as advancements in genetic testing technologies, increasing prevalence of genetic diseases and growing awareness are driving the global genetic testing market. In addition, government initiatives and increased R&D activities in the field have been driving the genetic testing market. However, high cost involved, lack of experienced professionals and stringent regulations in some regions is restraining the global genetic testing market.
You Can Buy This PMR Healthcare Report From Here @ https://www.persistencemarketresearch.com/checkout/3175
Innovation of some new techniques for genetic testing, increased efficiency and accuracy are expected to offer good opportunities for global genetic testing market. In addition, emerging markets hold good potential for growth of genetic testing market due to rising patient pool and growing awareness in these regions. Some of the major trends that have been observed in the genetic testing market are shift of focus from clinical science to bioinformatics and growing popularity of these techniques, leading to high rate of adoption of genetic testing technology.
Some of the major companies dealing in genetic testing market are Abbott Laboratories, BioRad Laboratories, Abbott Molecular Inc., AutoGenomics Inc., Celera Group, PerkinElmer Inc., Quest Diagnostics Inc., ELITech Group, Roche Diagnostics Corp., Applied Biosystems Inc., Roche Molecular Diagnostics Inc., Transgenomic Inc. and others.

Genetic analyzers are automated systems capable of sequencing DNA or analyzing fragments for a variety of applications. In capillary electrophoresis-based systems, DNA fragments bound to probes migrate through a polymer, and the fluorescence emissions are measured. The genetic analyzer market is anticipated to grow due to the advancement of new technology and the rise in the geriatric population. However, the high cost of genetic analyzers resulting in their availability in a limited number of research organizations is restraining the market growth. Moreover, initiatives taken by governments and an increase in R&D investment and activities in the genetic field is expected to benefit the growth of the market.
Some of the key players of Genetic Analyzer Market: Abbott laboratories, Applied Biosystems, AutoGenomics, Biocompare, Bio-Rad Laboratories, Inc., ELITech Group, MYCO Instrumentation, Inc., PerkinElmer Inc., Quest Diagnostics, Thermo Fisher Scientific
Get Sample Copy of this Report @ https://www.reportsweb.com/inquiry&RW00013261280/sample
The Global Genetic Analyzer Market research report offers an in-depth analysis of the global market, providing relevant information for the new market entrants or well-established players. Some of the key strategies employed by leading key players operating in the market and their impact analysis have been included in this research report.
Segmentation by product type: DNA Microarrays
PCR
Next Generation Sequencing
Serial Analysis of Gene Expression
Northern Blotting
Segmentation by application: Diagnostics Centres
Drug Discovery
Research and Development
Others
Get Discount for This Report @ https://www.reportsweb.com/inquiry&RW00013261280/discount
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Genetic Analyzer market based on product and application. It also provides market size and forecast till 2027 for overall Genetic Analyzer market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments.
Fundamentals of Table of Content:
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.5 Market by Application 1.6 Study Objectives 1.7 Years Considered
2 Global Growth Trends 2.1 Genetic Analyzer Market Size 2.2 Genetic Analyzer Growth Trends by Regions 2.3 Industry Trends
3 Market Share by Key Players 3.1 Genetic Analyzer Market Size by Manufacturers 3.2 Genetic Analyzer Key Players Head office and Area Served 3.3 Key Players Genetic Analyzer Product/Solution/Service 3.4 Date of Enter into Genetic Analyzer Market 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product 4.1 Global Genetic Analyzer Sales by Product 4.2 Global Genetic Analyzer Revenue by Product 4.3 Genetic Analyzer Price by Product
5 Breakdown Data by End User 5.1 Overview 5.2 Global Genetic Analyzer Breakdown Data by End User
Continue for TOC………
Purchase This Report @ https://www.reportsweb.com/inquiry&RW00013261280/buying

Global gene expression analysis market was valued US$ 4.2 Bn in 2017 and is expected to reach US$ 8.6 Bn by 2026, at a CAGR of 9.37 % during a forecast period.
Global Gene Expression Analysis Market
Gene expression is a procedure of deriving information from a gene to synthesize a functional gene product. Rising use of gene expression analysis in precision medicine provides key opportunities for the market during the forecast period.
Falling cost of sequencing, technological advancements, increasing the prevalence of cancer, and availability of government funding are propelling the market growth. Novel technologies to aid gene expression studies, rising application areas of gene expression, and availability of gene expression databases are boosting the growth the global gene expression analysis market. Currency Devaluation is a major challenge of the market. The high cost of instruments and lack of trained professionals are hindering the market growth.
The growing volume of genetic tests in drug & biomarker discovery and pharmacogenomics applications are driving the growth of the consumables market. The rising installation of NGS & PCR tools worldwide will significantly boost the demand for consumables. PCR analysis is estimated to the largest revenue share owing to high adoption & introduction of systems integrated with other steps as well as techniques.
Pharmaceutical & biotechnology companies utilize gene expression analysis products & services to achieve their clinical research goals like drug discovery & development and biotech research. The high volume of research studies involving gene expression analysis and huge capital for high-end analysis instruments & consumables is expected to grow at the highest rate during the forecast period in the pharmaceutical and biotechnology segment.
The Asia Pacific market is expected to grow at the highest rate during the forecast period owing to the domestic manufacturing of sequencing systems, western partnerships to improve healthcare, high R&D intensity, government focus on cancer and other life science research, and flourishing bioresearch centers.
Key player operating in global gene expression analysis market are Agilent Technologies, BGI, Bio-Rad Laboratories, Inc., Eurofins Scientific, F. Hoffmann-La Roche, GE Healthcare, Illumina, Inc., Oxford Gene Technology, Pacific Biosciences of California, Inc., Perkinelmer, Inc., Qiagen N.V., and Thermo Fisher Scientific, Inc.
The Scope of Global Gene Expression Analysis Market:
Global Gene Expression Analysis Market, by Products & Services:
• Consumables
• Instruments
• Services
Global Gene Expression Analysis Market, by End User:
• Pharmaceutical & Biotech companies
• Academic Institutes & Research Centers
• Other End User
Global Gene Expression Analysis Market, by Region:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa
Key Player Operating in Global Gene Expression Analysis Market:
• Agena Bioscience
• Applied Microarrays
• Arrayit
• AutoGenomics
• BD
• Beijing Genomics Institute
• BioChain Institute
• Biometrix Technology
• Cepheid
• CombiMatrix
• Danaher
• Danyel Biotech
• EMD Millipore
• Eppendorf
• Exiqon
• Fluidigm
• GE Healthcare
• Great Basin
• LC Sciences
• Luminex
• Microarrays
• Miltenyi Biotec
• OriGene Technologies
• Oxford Gene Technology
• Oxford Nanopore Technologies
• Partek
• Perkin Elmer
• Phalanx Biotech Group
• Promega
• Takara Bio
• Tecan
• Veredus Laboratories
• Zyagen.
​
For More Information Visit:https://www.maximizemarketresearch.com/market-report/global-acetone-market/24979/
This Report Is Submitted By @Global Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact Us:
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH
Email: sales@maximizemarketresearch.com
Contact: +91 9607365656

Global Metagenomics Market was valued US$ 178 Mn in 2017 and is expected to reach US$ 568 Mn by 2026, at a CAGR of 15.61% during a forecast period.
​
The metagenomics market is segmented into the technology, product, application, and region.
In terms of technology, the global metagenomics market is classified into sequencing and bioinformatics. Based on the product, the global metagenomics market is divided into instruments, software, and consumables. A further application, global medical gas, and equipment market are split environmental, human health, and others.
​
Based on regions, the global metagenomics market is divided into five main regions are America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
​
​
In terms of technology, the sequencing-driven segment accounted for the largest revenue share in the metagenomics market owing to the higher implementation of this technology. High adoption of this technology can be attributed to the advent of novel bioinformatics-related solutions, which simplifies workflows and provides rapid results.
​
Based on application, environmental applications segment is anticipated to grow at a faster CAGR during the forecast period. Environmental applications include use in the agriculture sector to support crop growth, bioremediation through wastewater treatment, clean-up of oil spills and gasoline leaks, and biofuel production by harnessing microbial power.
​
The major driving factor of the global metagenomics market is the surge in the metagenomics experiments collaboration and adoption of metagenomics applications. Additionally, growing advanced sequencing platforms is also boosting the market growth.
​
Lack of skilled professionals and stringent regulation are hampering the growth of the global metagenomics market. Limitations in bioinformatics and the use of data is the major challenge of the global metagenomics market.
​
Some opportunity of the global metagenomics market is growing in awareness in the developing economies as well as advancements in next-generation sequencing.
​
Geographically, the Asia-Pacific market is anticipated to the fastest-growing region for the metagenomics market. The Asia-Pacific metagenomics market is anticipated to grow rapidly due to the high incidence of cancer, large prevalence of target diseases, growing healthcare expenditure, rise in investments and funds and various emerging applications.
​
Key players operating in global metagenomics market are QIAGEN, Hoffmann-La Roche Ltd, Illumina, Inc., Novogene Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Thermo Fisher, Scientific, Inc., Merck KGaA, Agilent Technologies, Promega Corporation, Luminex Corporation, Oxford Gene Technology, Inc., TAKARA BIO INC., Danaher, ELITechGroup, AutoGenomics, Biocartis Group NV, IntegraGen., ChunLab, Inc., and UBiome, Inc.
​
For More Information Visit@ https://www.maximizemarketresearch.com/market-report/global-metagenomics-market/21652/
​
Scope of Global Metagenomics Market:
​
Metagenomics Market, by Technology:
​
• Sequencing
• Bioinformatics
Metagenomics Market, by Product:
​
• Instruments
• Software
• Consumables
Metagenomics Market, by Application:
​
• Environmental
• Human Health
• Others
Metagenomics Market, by Region:
​
• North America
• Europe
• Middle East & Africa
• Asia Pacific
• Latin America
Key Players Operating In Global Metagenomics Market:
​
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Novogene Corporation
• PerkinElmer Inc.
• Bio-Rad Laboratories
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Agilent Technologies
• Promega Corporation
• Luminex Corporation
• Oxford Gene Technology, Inc.
• TAKARA BIO INC.
• Danaher
• ELITechGroup
• AutoGenomics
• Biocartis Group NV
• IntegraGen.
• ChunLab, Inc.
• UBiome, Inc.
​
This Report Is Submitted By @Maximize Market Research Company
​
Customization of the report:
​
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
​
About Maximize Market Research:
​
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
​
Contact info:
​
Name: Lumawant Godage
​
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
​
Email: [sales@maximizemarketresearch.com](mailto:sales@maximizemarketresearch.com)
​
Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.
​
Contact: +919607195908